Detalhe da pesquisa
1.
Is impaired response to PD-1 blockers of high serum PD-1 patients related to immune complexes?
Ann Oncol
; 32(6): 814-816, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33684461
2.
Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy.
Br J Cancer
; 111(7): 1350-62, 2014 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25101565
3.
Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells.
J Exp Med
; 190(2): 205-15, 1999 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-10432284
4.
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.
J Exp Med
; 180(1): 347-52, 1994 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7516411
5.
Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35).
J Exp Med
; 184(2): 647-57, 1996 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-8760818
6.
Tumour-released exosomes and their implications in cancer immunity.
Cell Death Differ
; 15(1): 80-8, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17932500
7.
Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting.
Cytokine Growth Factor Rev
; 44: 1-10, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30393044
8.
beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.
J Clin Invest
; 101(12): 2720-9, 1998 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-9637706
9.
Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
Cancer Res
; 51(11): 2897-901, 1991 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2032228
10.
Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides.
Cancer Res
; 55(21): 4972-9, 1995 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7585538
11.
T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
Cancer Res
; 57(23): 5320-7, 1997 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-9393756
12.
Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytes.
Cancer Res
; 48(9): 2372-6, 1988 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-3258541
13.
Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells.
Cancer Res
; 61(1): 222-7, 2001 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11196165
14.
Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.
Cancer Res
; 55(14): 3149-57, 1995 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-7541714
15.
Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35).
Cancer Res
; 58(11): 2433-9, 1998 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-9622085
16.
A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy.
Cancer Res
; 59(2): 301-6, 1999 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-9927036
17.
Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer.
Cancer Res
; 60(17): 4850-4, 2000 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-10987297
18.
Differences between in vivo and in vitro activation of cancer patient lymphocytes by recombinant interleukin 2: possible role for lymphokine-activated killer cell infusion in the in vivo-induced activation.
Cancer Res
; 49(18): 5230-4, 1989 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-2788498
19.
In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.
Cancer Res
; 50(17): 5551-7, 1990 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2386961
20.
Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.
Cancer Res
; 54(20): 5265-8, 1994 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-7522957